What is the address of BOUSCAS MED?

The registered office of BOUSCAS MED is located at Alsembergsesteenweg 1084 box 5, 1180 Ukkel.

Is BOUSCAS MED still active?

Yes. According to the CBE (30 October 2026) BOUSCAS MED is active, legal situation “Normale toestand”, started on 7 July 2022.

Is BOUSCAS MED registered on Peppol?

No, BOUSCAS MED is currently not registered on the Peppol network.

What is the enterprise number of BOUSCAS MED?

The enterprise number of BOUSCAS MED is BE0788352256.

When was BOUSCAS MED founded?

BOUSCAS MED was founded on 7 July 2022.

Who owns BOUSCAS MED?

The shares are held by BOUSCAS (80.6%).

Is BOUSCAS MED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 July 2022; 3 annual accounts filed, latest fiscal year 2025.

How much profit did BOUSCAS MED make in 2025?

BOUSCAS MED recorded a loss after taxes of € 4,460 in financial year 2025.

What is the revenue of BOUSCAS MED?

As a small company, BOUSCAS MED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -4,424.

How many employees does BOUSCAS MED have?

According to the 2025 annual accounts, BOUSCAS MED has 0 full-time equivalents (FTE).

BOUSCAS MED (Private Limited) - Ukkel - BE0788352256

Dossier BOUSCAS MED, printed on 30 October 2026 from databakkes.be/en/0788352256/bouscas-med. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Busy address KBO

22 other companies have their registered office at the same address; threshold 10.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

BOUSCAS MED from Ukkel, company number BE0788352256, closed financial year 2025 with a result of € -4,460 after tax. For that financial year BOUSCAS MED recorded a gross margin of € -4,424 and equity of € 4.5 million. Compared with financial year 2024, the result moved from € -7,275 to € -4,460. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Healthy

€ 4.5 million

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -4,460

▲ 39 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 86,307

▲ € 81,171 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -22,668.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Debts at end 2025

Bank debt

€ 134,208

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 1,003

▲ 159% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -10,830 Gross margin 2023: € -10,830 First fiscal year in the series	€ -7,227 Gross margin 2024: € -7,227 ▲ € 3,603 vs 2023 (€ -10,830) Favourable step	€ -4,424 Gross margin 2025: € -4,424 ▲ € 2,803 vs 2024 (€ -7,227) Favourable step	▲ € 2,803
Profit after taxes	€ -10,932 Profit after taxes 2023: € -10,932 First fiscal year in the series	€ -7,275 Profit after taxes 2024: € -7,275 ▲ € 3,657 vs 2023 (€ -10,932) Favourable step	€ -4,460 Profit after taxes 2025: € -4,460 ▲ € 2,815 vs 2024 (€ -7,275) Favourable step	▲ € 2,815
Equity	€ 5,165,708 Equity 2023: € 5,165,708 First fiscal year in the series	€ 4,532,960 Equity 2024: € 4,532,960 ▼ 12% vs 2023 (€ 5,165,708) Unfavourable step	€ 4,528,500 Equity 2025: € 4,528,500 Unchanged (€ 4,532,960) Unfavourable step
Total debts	€ 109,411 Total debts 2023: € 109,411 First fiscal year in the series	€ 252,173 Total debts 2024: € 252,173 ▲ 130% vs 2023 (€ 109,411) Unfavourable step	€ 387,788 Total debts 2025: € 387,788 ▲ 54% vs 2024 (€ 252,173) Unfavourable step	▲ 54%
Cash	€ 3,857 Cash 2023: € 3,857 First fiscal year in the series	€ 5,136 Cash 2024: € 5,136 ▲ 33% vs 2023 (€ 3,857) Favourable step	€ 86,307 Cash 2025: € 86,307 ▲ € 81,171 vs 2024 (€ 5,136) Favourable step	▲ € 81,171
Retained profit	€ -10,932 Retained profit 2023: € -10,932 First fiscal year in the series	€ -18,208 Retained profit 2024: € -18,208 ▼ € 7,275 vs 2023 (€ -10,932) Unfavourable step	€ -22,668 Retained profit 2025: € -22,668 ▼ € 4,460 vs 2024 (€ -18,208) Unfavourable step	▼ € 4,460
Bank debt	€ 0 Bank debt 2023: € 0 First fiscal year in the series	€ 134,208 Bank debt 2024: € 134,208 Unchanged (€ 0) Unfavourable step	€ 134,208 Bank debt 2025: € 134,208 Unchanged (€ 134,208) Unchanged
Balance sheet total	€ 5,275,118 Balance sheet total 2023: € 5,275,118 First fiscal year in the series	€ 4,785,133 Balance sheet total 2024: € 4,785,133 ▼ 9% vs 2023 (€ 5,275,118) Unchanged	€ 4,916,289 Balance sheet total 2025: € 4,916,289 ▲ 3% vs 2024 (€ 4,785,133) Unchanged	▲ 3%

Key figures of BOUSCAS MED, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BOUSCAS MED?

What happened at BOUSCAS MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 2, 2026 New annual accounts for financial year 2025: loss of € 4,460. Source: NBB ↗
Jul 7, 2022 Start of the company according to the CBE. KBO

In short

From € 10,932 loss in 2023 to € 4,460 loss in 2025.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Alsembergsesteenweg 1084 box 5

1180 Ukkel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 22 companies are registered at this address.

All companies at this address →

REGIE CONSTELLATION

€ 185,913 gross margin · 2025

ïOD & CIE

€ 6,930 gross margin · 2025

CENTURICAL

€ 507 gross margin · 2025

CASSETTE INVEST

€ -116,319 gross margin · 2025

ExportUSA

€ -2,595 gross margin · 2025

+17 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0788.352.256
VAT number: BE 0788.352.256
Registered office: Alsembergsesteenweg 1084 bus 5, 1180 Ukkel
Names & denominations: BOUSCAS MED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 7 July 2022
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗

BOUSCAS MED